
    
      After assessing eligibility during a screening period of up to 4 weeks, up to 6 subjects will
      be included.

      Subjects will check into the clinic one day prior to dosing (Day -1). To evaluate and compare
      drug exposure levels in plasma and CSF, plasma and CSF will be serially sampled over a period
      of 36 hours. Subjects will be discharged from the clinic on Day 5 after all required study
      procedures are completed and if medically justified.

      Subjects will return to the clinic approximately 1 week after discharge from the clinic for a
      follow-up visit.
    
  